ScienceTop StoryTop StoryLatest News
MIT Scientists Turn Immune Cells into Cancer Killers Inside the Body
Sentiment: PositiveHigh Priority
What Happened?
MIT researchers have developed a technique to transform immune cells into cancer fighters directly within the body, simplifying cancer and autoimmune disease treatments. The method utilizes natural killer (NK) cells, which can be engineered to target harmful cells.
Key points
- MIT researchers focus on natural killer (NK) cells to combat cancer and autoimmune diseases.
- The new technique delivers genetic instructions directly to NK cells using lipid nanoparticles.
- Approximately 80% of targeted NK cells were successfully modified in initial experiments.
- In mice, engineered NK cells led to complete remission in melanoma cases.
- The approach also showed promise in treating autoimmune hepatitis by eliminating harmful T cells.
Key insights
- The ability to engineer NK cells in vivo could revolutionize cancer treatment methodologies.
- This technique may reduce the costs and complexities associated with traditional CAR T cell therapies.
- If successful in humans, this approach could expand treatment options for various autoimmune diseases.
Why it matters
This research could simplify the production of personalized cancer therapies, making them more accessible to patients.
Tags
Entities
MIT· OrganizationNature Biotechnology· EventDaniel Anderson· PersonYuang Chen· PersonJulia Monkovic· PersonHaseeb Mughal· PersonRobert Langer· PersonSanofi· OrganizationNational Cancer Institute· Organization
Source
Science Daily
